These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 5961369)

  • 1. Separation of plasminogen activators from normal and lytic human plasma.
    Hamberg U
    Life Sci; 1966 Apr; 5(8):731-41. PubMed ID: 5961369
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on plasminogen activators. I. Sucrose density gradient distribution of activators from normal and lytic human plasma.
    Hamberg U
    Acta Chem Scand; 1966; 20(9):2539-50. PubMed ID: 5965137
    [No Abstract]   [Full Text] [Related]  

  • 3. In vitro comparison of fibrinolytic activity of plasminogen activators using a thrombelastographic method: in vivo evaluation of the B-chain-streptokinase complex in the dog model using pre-titered doses.
    Summaria L; Sandesara J; Yang G; Vagher JP; Caprini JA
    Thromb Haemost; 1986 Aug; 56(1):71-9. PubMed ID: 2946093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Proactivator-activator system in human plasma fibrinolysis: studies on the synthetic fibrinolytic system composed of functionally pure fibrinogen, plasminogen and proactivator, separated from human plasma].
    Okamoto U
    Nihon Seirigaku Zasshi; 1972 Mar; 34(3):147-55. PubMed ID: 4262660
    [No Abstract]   [Full Text] [Related]  

  • 5. In vitro effects of the acylated streptokinase-plasminogen activator complex BRL 33 575 incubated with normal human plasma.
    Lämmle B; Noll G; Tran TH; Lohri A; Duckert F
    Thromb Haemost; 1984 Jul; 51(3):403-5. PubMed ID: 6548585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A STANDARD CLOT METHOD FOR THE ASSAY OF PLASMINOGEN ACTIVATORS, ANTI-ACTIVATORS, AND PLASMIN.
    HAWKEY CM; STAFFORD JL
    J Clin Pathol; 1964 Mar; 17(2):175-81. PubMed ID: 14149945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A method for separation of plasminogen from bovine plasma fraction. I. With reference to some properties of the plasminogen].
    Okamoto U; Matumoto M
    Nihon Seirigaku Zasshi; 1971; 33(7):394-402. PubMed ID: 4255047
    [No Abstract]   [Full Text] [Related]  

  • 8. Separation of SK-plasminogen-complex in sera and euglobulin solution of cat and monkey by gel filtration using sephadex G-200.
    Nitta H; Sugie I; Ikai M; Ozio M; Takahashi N
    Nagoya Med J; 1969 Jul; 15(2):93-102. PubMed ID: 4981466
    [No Abstract]   [Full Text] [Related]  

  • 9. Plasminogen in human saliva.
    Moody GH
    Int J Oral Surg; 1982 Apr; 11(2):110-4. PubMed ID: 6809670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraarterial fibrinolysis: in vitro and prospective clinical evaluation of three thrombolytic agents.
    Pilger E; Lammer J; Bertuch H; Steiner H
    Radiology; 1986 Dec; 161(3):597-9. PubMed ID: 3786705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [MEASURE OF PLASMA RESISTANCE TO LYSIS BY STREPTOKINASE. APPLICATION TO PATHOLOGIC THROMBOSIS. NEW TECHNIQUE FOR THE MEASUREMENT OF ACTIVATION OF PLASMINOGEN INHIBITORS].
    VAIREL EG; THELY MH
    Sangre (Barc); 1964; 41():447-50. PubMed ID: 14248833
    [No Abstract]   [Full Text] [Related]  

  • 12. Plasminogen activation: biochemistry, physiology, and therapeutics.
    Wun TC
    Crit Rev Biotechnol; 1988; 8(2):131-48. PubMed ID: 2976309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of adenine nucleotides on the activator function of streptokinase].
    Nikandrov VN; Pyzhova NS; Votiakov VI
    Biull Eksp Biol Med; 1987 Jul; 104(7):49-51. PubMed ID: 3620649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of various combinations of plasminogen and streptokinase on fibrinolysis.
    Gaffney PJ; Joe F; Rowe EA; Whitaker AN
    Haemostasis; 1981; 10(6):304-14. PubMed ID: 7327440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of coagulation and fibrinolysis after intravenous anisoylated plasminogen streptokinase activator complex or heparin in patients with acute myocardial infarction. A Belgian multicentre study.
    Renkin J; Beys CC; Lavenne-Pardonge E; Pintens H; Col J
    Drugs; 1987; 33 Suppl 3():253-60. PubMed ID: 3315603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The interaction of streptokinase.plasminogen activator complex, tissue-type plasminogen activator, urokinase and their acylated derivatives with fibrin and cyanogen bromide digest of fibrinogen. Relationship to fibrinolytic potency in vitro.
    Cassels R; Fears R; Smith RA
    Biochem J; 1987 Oct; 247(2):395-400. PubMed ID: 3122725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ACTIVATION OF PARTIALLY PURIFIED PLASMINOGEN IN THE PRESENCE OF EPSILON-AMINOCAPROIC ACID. A TECHNIQUE FOR PREPARING PLASMIN FREE OF EXTRINSIC ACTIVATORS.
    DONALDSON VH
    J Lab Clin Med; 1964 Feb; 63():213-23. PubMed ID: 14125108
    [No Abstract]   [Full Text] [Related]  

  • 18. [Animal experimental studies on fibrinolysis with streptokinase].
    Hauptmann J; Klöcking HP
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1979; 106(5-6):915-22. PubMed ID: 94886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On a plasminogen activator from human plasma.
    Batista AD; Solana GH; Almonte JF
    Thromb Haemost; 1980 Feb; 42(5):1607-14. PubMed ID: 6899948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FIBRINOLYTIC AND ESTEROLYTIC ACTIVITY OF HUMAN PLASMA.
    ADAMIS DM; MANIATIS GM
    Thromb Diath Haemorrh; 1965 Jun; 13():484-91. PubMed ID: 14347870
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.